{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32082399", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "30"}], "Language": ["eng"], "ELocationID": ["9257950", "10.1155/2020/9257950"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Oroxylin A Reduces Vasoconstriction in Rat Aortic Rings through Promoting NO Production and NOS Protein Expression via Estrogen Receptor Signal Pathway.", "Pagination": {"StartPage": "9257950", "MedlinePgn": "9257950"}, "Abstract": {"AbstractText": ["Oroxylin A, a flavonoid, is naturally produced in many medicinal plants. Our previous study identified it as a phytoestrogen. Based on this, the present study investigated its vasoconstriction reducing effects and whether the action was mediated by the estrogen receptor (ER) signal pathway. Long-term in vitro treatment with oroxylin A reduced Ach-induced vasorelaxation and NE-mediated or KCl-mediated contractile responses in rat aortic rings. These effects were interfered by an ER inhibitor ICI 182,780. Rat cardiac microvascular endothelial cells (CMECs) and aortic vascular smooth muscle cells (VSMCs) were used to study the possible underlying mechanisms. Oroxylin A activated the ER signal pathway. In CMECs, it increased NO production and eNOS protein expression. In VSMCs, it promoted NO production and iNOS protein expression. These effects were also inhibited by ICI 182,780. Besides, oroxylin A stimulated ER<i>\u03b1</i> and ER<i>\u03b2</i> protein expression in CMECs and VSMCs. All these findings suggest that the ER signal pathway takes part in the vasoconstriction reducing effects of oroxylin A."], "CopyrightInformation": "Copyright \u00a9 2020 Jingtian Qu et al."}, "AuthorList": [{"Identifier": ["0000-0001-7913-6784"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, 314 Anshanxi Road, Nankai District, Tianjin 300193, China."}], "LastName": "Qu", "ForeName": "Jingtian", "Initials": "J"}, {"Identifier": ["0000-0002-9004-1599"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, 314 Anshanxi Road, Nankai District, Tianjin 300193, China."}], "LastName": "Liu", "ForeName": "Fang", "Initials": "F"}, {"Identifier": ["0000-0002-3016-1556"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, 314 Anshanxi Road, Nankai District, Tianjin 300193, China."}], "LastName": "Zhang", "ForeName": "Xuezhu", "Initials": "X"}, {"Identifier": ["0000-0002-1463-5512"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 5 Beixiange, Xicheng District, Beijing 100053, China."}], "LastName": "Wang", "ForeName": "Jialong", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors have declared that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Iorga A., Cunningham C. M., Moazeni S., Ruffenach G., Umar S., Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biology of Sex Differences. 2017;8(1):p. 33. doi: 10.1186/s13293-017-0152-8.", "ArticleIdList": ["10.1186/s13293-017-0152-8", "PMC5655818", "29065927"]}, {"Citation": "Hurtado R., Celani M., Geber S. Effect of short-term estrogen therapy on endothelial function: a double-blinded, randomized, controlled trial. Climacteric. 2016;19(5):448\u2013451. doi: 10.1080/13697137.2016.1201809.", "ArticleIdList": ["10.1080/13697137.2016.1201809", "27427235"]}, {"Citation": "Cushman M., Larson J. C., Rosendaal F. R., et al. Biomarkers, menopausal hormone therapy and risk of venous thrombosis: the women\u2019s health initiative. Research and Practice in Thrombosis and Haemostasis. 2018;2(2):310\u2013319. doi: 10.1002/rth2.12100.", "ArticleIdList": ["10.1002/rth2.12100", "PMC5974918", "30046733"]}, {"Citation": "Simin J., Tamimi R., Lagergren J., Adami H.-O., Brusselaers N. Menopausal hormone therapy and cancer risk: an overestimated risk? European Journal of Cancer. 2017;84:60\u201368. doi: 10.1016/j.ejca.2017.07.012.", "ArticleIdList": ["10.1016/j.ejca.2017.07.012", "28783542"]}, {"Citation": "Wei L., Zhou Y., Qiao C., et al. Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1alpha destabilization. Cell Death & Disease. 2015;6(4) doi: 10.1038/cddis.2015.86.e1714", "ArticleIdList": ["10.1038/cddis.2015.86", "PMC4650553", "25855962"]}, {"Citation": "Lu Z., Lu N., Li C., et al. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. Toxicology Letters. 2012;209(3):211\u2013220. doi: 10.1016/j.toxlet.2011.12.022.", "ArticleIdList": ["10.1016/j.toxlet.2011.12.022", "22245252"]}, {"Citation": "Ku S. K., Lee I. C., Bae J. S. Antithrombotic activities of oroxylin A in vitro and in vivo. Archives of Pharmacal Research. 2014;37(5):670\u2013686. doi: 10.1007/s12272-013-0233-0.", "ArticleIdList": ["10.1007/s12272-013-0233-0", "23963976"]}, {"Citation": "Wang H., Guo Y., Zhao X., et al. An estrogen receptor dependent mechanism of oroxylin A in the repression of inflammatory response. PLoS One. 2013;8(7) doi: 10.1371/journal.pone.0069555.e69555", "ArticleIdList": ["10.1371/journal.pone.0069555", "PMC3726624", "23922737"]}, {"Citation": "Akinyi M., Gao X. M., Li Y. H., et al. Vascular relaxation induced by Eucommiae Ulmoides Oliv. and its compounds oroxylin A and wogonin: implications on their cytoprotection action. International Journal of Clinical and Experimental Medicine. 2014;7(10):3164\u20133180.", "ArticleIdList": ["PMC4238523", "25419347"]}, {"Citation": "Wang H., Qu J. T., Zhao X., Guo Y., Mao H. P. Vasodilator effect of oroxylin A on thoracic aorta isolated from rats. Journal of Chinese Integrative Medicine. 2012;10(8):880\u2013885. doi: 10.3736/jcim20120808.", "ArticleIdList": ["10.3736/jcim20120808", "22883404"]}, {"Citation": "Binko J., Majewski H. 17\u03b2-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. American Journal of Physiology-Heart and Circulatory Physiology. 1998;274(3):H853\u2013H859. doi: 10.1152/ajpheart.1998.274.3.h853.", "ArticleIdList": ["10.1152/ajpheart.1998.274.3.h853", "9530196"]}, {"Citation": "Liu H., Tao Y., Chen M., et al. 17\u03b2-Estradiol promotes angiogenesis of rat cardiac microvascular endothelial cells in vitro. Medical Science Monitor. 2018;24:2489\u20132496. doi: 10.12659/msm.903344.", "ArticleIdList": ["10.12659/msm.903344", "PMC5936052", "29684003"]}, {"Citation": "Fredette N. C., Meyer M. R., Prossnitz E. R. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation. The Journal of Steroid Biochemistry and Molecular Biology. 2018;176(3):65\u201372. doi: 10.1016/j.jsbmb.2017.05.006.", "ArticleIdList": ["10.1016/j.jsbmb.2017.05.006", "PMC5694388", "28529128"]}, {"Citation": "Mazzuca M. Q., Mata K. M., Li W., Rangan S. S., Khalil R. A. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]i in mesenteric microvessels of female rat. The Journal of Pharmacology and Experimental Therapeutics. 2015;352(2):291\u2013304. doi: 10.1124/jpet.114.219865.", "ArticleIdList": ["10.1124/jpet.114.219865", "PMC4293436", "25472954"]}, {"Citation": "Lai N., Lu W., Wang J. Ca(2+) and ion channels in hypoxia-mediated pulmonary hypertension. International Journal of Clinical and Experimental Pathology. 2015;8(2):1081\u20131092.", "ArticleIdList": ["PMC4396234", "25972995"]}, {"Citation": "Leblanc N., Forrest A. S., Ayon R. J., et al. Molecular and functional significance of Ca2+-activated Cl\u2212 channels in pulmonary arterial smooth muscle. Pulmonary Circulation. 2015;5(2):244\u2013268. doi: 10.1086/680189.", "ArticleIdList": ["10.1086/680189", "PMC4449236", "26064450"]}, {"Citation": "Shimokawa H. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pfl\u00fcgers Archiv\u2014European Journal of Physiology. 2010;459(6):915\u2013922. doi: 10.1007/s00424-010-0790-8.", "ArticleIdList": ["10.1007/s00424-010-0790-8", "20140449"]}, {"Citation": "Chakrabarti S., Morton J. S., Davidge S. T. Mechanisms of estrogen effects on the endothelium: an overview. Canadian Journal of Cardiology. 2014;30(7):705\u2013712. doi: 10.1016/j.cjca.2013.08.006.", "ArticleIdList": ["10.1016/j.cjca.2013.08.006", "24252499"]}, {"Citation": "Usselman C. W., Stachenfeld N. S., Bender J. R. The molecular actions of oestrogen in the regulation of vascular health. Experimental Physiology. 2016;101(3):356\u2013361. doi: 10.1113/ep085148.", "ArticleIdList": ["10.1113/ep085148", "PMC4947570", "26778523"]}, {"Citation": "Anagnostis P., Paschou S. A., Katsiki N., Krikidis D., Lambrinoudaki I., Goulis D. G. Menopausal hormone therapy and cardiovascular risk. Where are we now? Current Vascular Pharmacology. 2018;16 doi: 10.2174/1570161116666180709095348.", "ArticleIdList": ["10.2174/1570161116666180709095348", "29984659"]}, {"Citation": "Tseng T.-L., Chen M.-F., Liu C.-H., Pang C.-Y., Hsu Y.-H., Lee T. J. F. Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock. British Journal of Pharmacology. 2016;173(7):1179\u20131195. doi: 10.1111/bph.13415.", "ArticleIdList": ["10.1111/bph.13415", "PMC5341340", "26694894"]}, {"Citation": "Yang D., Fu X. D., Li Y. Y., Tan Z., Wang T. H., Pan J. Y. Role of inducible nitric oxide synthase in the vascular smooth muscle cells cycle arrest induced by 17 beta-estradiol. Sheng Li Xue Bao. 2003;55(6):684\u2013691.", "ArticleIdList": ["14695486"]}, {"Citation": "Zancan V., Santagati S., Bolego C., Vegeto E., Maggi A., Puglisi L. 17-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells. Endocrinology. 1999;140(5):2004\u20132009. doi: 10.1210/en.140.5.2004.", "ArticleIdList": ["10.1210/en.140.5.2004", "10218948"]}, {"Citation": "Saito S., Aras R. S., Lou H., Ramwell P. W., Foegh M. L. Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells. The Journal of Heart and Lung Transplantation. 1999;18(10):937\u2013945. doi: 10.1016/s1053-2498(99)00060-1.", "ArticleIdList": ["10.1016/s1053-2498(99)00060-1", "10561103"]}, {"Citation": "Bernardini C., Greco F., Zannoni A., Bacci M. L., Seren E., Forni M. Differential expression of nitric oxide synthases in porcine aortic endothelial cells during LPS-induced apoptosis. Journal of Inflammation. 2012;9(1):p. 47. doi: 10.1186/1476-9255-9-47.", "ArticleIdList": ["10.1186/1476-9255-9-47", "PMC3542028", "23181483"]}]}], "History": [{"Year": "2019", "Month": "6", "Day": "29"}, {"Year": "2019", "Month": "9", "Day": "10"}, {"Year": "2019", "Month": "9", "Day": "18"}, {"Year": "2020", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["32082399", "PMC7011478", "10.1155/2020/9257950"]}}]}